Treatment, Education, and Prevention: Adding to the Arsenal in the War on Drugs. Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, First Session.

A hearing was held on the role of prevention in the comprehensive drug control policy of the United States. The hearing demonstrated a strengthening of the commitment to reduce the demand for drugs. It also showed bi-partisan support to remain vigilant in defense of the borders and in punishing those who sell or manufacture drugs. It states that the time has come to increase resources towards prevention. Following opening statements from Senators Orrin G. Hatch, Patrick J. Leahy, Mike Dewine, Richard J. Durbin, Maria Cantwell, Russell D. Feingold, and Srom Thurmond, expert witnesses presented testimony about what works in drug prevention. The panelists included Dr. Robert DuPont, president of Institute for Behavior and Health, Inc.; Edyie Hewitt, former director of Vermont Federation of Families for Children's Mental Health; Alan I. Leshner, National Institute on Drug Abuse; Donnie R. Marshall, Drug Enforcement Administration; Carroll O'Connor, actor and advocate for prevention; Debra Walcott, recovering drug addicted youth; James A. Walton, Jr., commissioner for the Department of Public Safety in Vermont; and Paul M. Warner, United States Attorney for the district of Utah. Statements were also submitted for the record from Joseph A. Califano, Jr., President of National Center on Addiction and Substance Abuse, Columbia University and Dr. Jan K. Carney, Commissioner of Health, State of Vermont. (JDM)